ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines

ClinicalTrials.gov ID: NCT06218251

Public ClinicalTrials.gov record NCT06218251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 7:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multi-center, Open-label Study to Evaluate Subject Satisfaction and Natural Outcomes Following Administration of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex in Subjects With Upper Facial Lines (Glabellar Lines, Lateral Canthal Lines, and Forehead Lines)

Study identification

NCT ID
NCT06218251
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
AbbVie
Industry
Enrollment
100 participants

Conditions and interventions

Interventions

  • BOTOX Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 4, 2024
Primary completion
Jul 24, 2024
Completion
Dec 16, 2024
Last update posted
Nov 23, 2025

2024

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
Skin Wellness Dermatology - Homewood /ID# 248469 Birmingham Alabama 35209-8314
The Research Center at The Maas Clinic /ID# 256633 San Francisco California 94115-1809
Pacific Clinical Innovations /ID# 248467 Vista California 92083-6030
Kavali Plastic Surgery and Skin Renewal Center /ID# 248472 Atlanta Georgia 30328
Tennessee Clinical Research Center /ID# 259161 Nashville Tennessee 37215-2885
Integrated Aesthetics - Spring /ID# 257738 Spring Texas 77388
SkinDC /ID# 248470 Arlington Virginia 22209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06218251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 23, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06218251 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →